Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ceruloplasmin pseudogene (CPP) refers to a genomic DNA sequence that closely resembles the functional ceruloplasmin (*CP*) gene but is considered non-functional due to mutations such as frameshifts or premature stop codons that preclude the production of an active protein product[3][4]. The CPP pseudogene shares high sequence homology (97%) with the wild-type *CP* gene, but contains deletions and duplications resulting in an inability to encode a functional protein, and there is no detectable transcript corresponding to this pseudogene in human liver[3]. While a few pseudogenes have emerging regulatory or RNA-level functions in the genome, there is currently no evidence that ceruloplasmin pseudogene has a known biological or therapeutic role, is involved in disease, or is a target for any approved or investigational drugs[3][4][7]. Explanation and considerations: - **Is_target:** False: Pseudogenes do not encode functional proteins and are not direct targets for drugs or therapies in the conventional sense[4][7]. - **Is_incorrect:** True: The query refers to a pseudogene as a therapeutic target, which is not applicable. "Ceruloplasmin pseudogene" is not considered a valid drug target, receptor, enzyme, transporter, or other functional biomolecule. - **Molecular_classifications:** Pseudogene is the only applicable category; it does not fit into classic target families like receptor, enzyme, or transporter. - **Biological functions, disease roles, interacting drugs, mechanisms of action, biomarkers, and safety concerns:** There is no established function or clinical significance for this pseudogene; standard annotations in these fields do not apply[3][4][7]. - **Aliases:** As a pseudogene, its main aliases are the formal gene designation ("CPP") and descriptive term ("ceruloplasmin pseudogene"). - **Description:** Clearly delineates it is a processed, non-functional copy, with no demonstrated functional relevance as a drug or biomarker target, and distinguishes it from the functional ceruloplasmin gene and protein[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ceruloplasmin pseudogene (CPP).